All Posts

The Federal Reserve’s rate cuts are reshaping the cost of capital across the economy. For cannabis operators, real estate investors, and REITs, easing brings both opportunities and risks. Learn how this cycle could reset valuations, unlock growth, and create new momentum in emerging industries.

The California cannabis industry faces mounting pressure from illicit operators, weak enforcement, and too few licensed storefronts. As the black market thrives, legal businesses are left struggling to compete. Learn why this imbalance threatens sustainability and what reforms could bring the industry back on track.

Last week, Donald Trump signaled he is considering rescheduling cannabis from Schedule 1 - a classification shared with heroin and deemed more dangerous than cocaine - to Schedule 3, where prescription drugs like Tylenol with codeine reside. This move could open the door to normalized banking, credit card payments at dispensaries, greater patient access, and potentially unlock sidelined investment capital. U.S. cannabis stocks reacted immediately, with some rising nearly 100%

The THC/CBD combination proved more effective than placebo across several measures. Freedom from the most bothersome symptom at two hours was 60.3% in the THC/CBD group compared to just 34.5% in the placebo group. Sustained pain relief was also significantly better at both 24 and 48 hours. Additionally, improvements were seen in photophobia and phonophobia, both common and debilitating migraine symptoms